» Articles » PMID: 6201857

Immunity and Protection Against Influenza Virus by Synthetic Peptide Corresponding to Antigenic Sites of Hemagglutinin

Overview
Specialty Science
Date 1984 Apr 1
PMID 6201857
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Four peptides have been synthesized, corresponding to different regions of the H3 influenza hemagglutinin, that are related to antigenic sites "A" and "B" of the molecule. The peptides consisted of the following sequences: 139-146, which forms the "loop" in the native hemagglutinin molecule, with either glycine or aspartic acid at position 144; 147-164, which contains part of antigenic determinant "B"; and 138-164, which comprises both the loop and the area 147-164. The peptides were conjugated to tetanus toxoid and used for immunization of rabbits and mice. All four conjugates elicited an immune response against the homologous peptides, but only the peptides 138-164 and 147-164 gave rise to antibodies that recognized and bound to the intact virus. Protection of mice against challenge infection with A/Eng/42/72 virus was achieved only by immunization with the conjugate (138-164)-TT, which led to partial protective effect. These data emphasize the role of molecular structure in determining the antigenic properties of synthetic peptides and indicate that the length of the peptide could be crucial for enforcing the right folding required to mimic the native structure.

Citing Articles

Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein.

Haynes J, Cunningham J, von Seefried A, Lennick M, Garvin R, Shen S Biotechnology (N Y). 2020; 4(7):637-641.

PMID: 32226216 PMC: 7097054. DOI: 10.1038/nbt0786-637.


Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein.

Bushnell R, Tobin J, Long J, Schultz-Cherry S, Chaudhuri A, Nara P Virol J. 2010; 7:200.

PMID: 20735849 PMC: 2939558. DOI: 10.1186/1743-422X-7-200.


Identification of a dual-specific T cell epitope of the hemagglutinin antigen of an h5 avian influenza virus in chickens.

Haghighi H, Read L, Haeryfar S, Behboudi S, Sharif S PLoS One. 2009; 4(11):e7772.

PMID: 19901990 PMC: 2770124. DOI: 10.1371/journal.pone.0007772.


Current approaches to vaccine preparation.

Liu J, Cepica A Can Vet J. 1990; 31(3):181-9.

PMID: 17423533 PMC: 1480769.


Recombinant protein comprising multi-neutralizing epitopes induced high titer of antibodies against influenza A virus.

Li H, Ding J, Chen Y Immunobiology. 2003; 207(5):305-13.

PMID: 14575146 PMC: 8673591. DOI: 10.1078/0171-2985-00244.


References
1.
Langbeheim H, Arnon R, Sela M . Antiviral effect on MS-2 coliphage obtained with a synthetic antigen. Proc Natl Acad Sci U S A. 1976; 73(12):4636-40. PMC: 431576. DOI: 10.1073/pnas.73.12.4636. View

2.
Arnon R, Shapira M, Jacob C . Synthetic vaccines. J Immunol Methods. 1983; 61(3):261-73. DOI: 10.1016/0022-1759(83)90220-x. View

3.
MERRIFIELD R . Automated synthesis of peptides. Science. 1965; 150(3693):178-85. DOI: 10.1126/science.150.3693.178. View

4.
Fazekas de St Groth , Webster R . Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med. 1966; 124(3):331-45. PMC: 2138235. DOI: 10.1084/jem.124.3.331. View

5.
Bizzini B, Blass J, Turpin A, Raynaud M . Chemical characterization of tetanus toxin and toxoid. Amino acid composition, number of SH and S-S groups and N-terminal amino acid. Eur J Biochem. 1970; 17(1):100-5. DOI: 10.1111/j.1432-1033.1970.tb01141.x. View